Shares of Curanex Pharmaceuticals Inc (NASDAQ:CURX – Get Free Report) traded up 1.6% during mid-day trading on Tuesday . The stock traded as high as $0.63 and last traded at $0.5951. 82,323 shares were traded during mid-day trading, a decline of 87% from the average session volume of 624,413 shares. The stock had previously closed at $0.5858.
Wall Street Analyst Weigh In
Separately, Wall Street Zen raised Curanex Pharmaceuticals to a “hold” rating in a research note on Saturday, August 30th.
Check Out Our Latest Stock Report on Curanex Pharmaceuticals
Curanex Pharmaceuticals Trading Up 1.6%
About Curanex Pharmaceuticals
Curanex is a developmental stage pharmaceutical company dedicated to discovering, developing and commercializing innovative botanical drugs to treat patients suffering from inflammatory diseases. Our mission is to address significant unmet medical needs and improve patients’ lives by harnessing the power of natural substances.
See Also
- Five stocks we like better than Curanex Pharmaceuticals
- What is a SEC Filing?
- CoreWeave’s Guidance Cut: A Buying Opportunity in Disguise?
- How to invest in marijuana stocks in 7 steps
- Strategy Shares Plunge as Bitcoin Retreats—More Pain Ahead?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- BigBear.ai Stock Is Range-Bound—Wall Street Isn’t Buying the Hype
Receive News & Ratings for Curanex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curanex Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
